Document is current

Article History

Received: 9 June 2025

Accepted: 6 July 2025

First Online: 14 July 2025

Declarations

:

: The respective ethical and research committee involving human beings approved the use of the randomized controlled trial ANDROMEDA-SHOCK (2). Data use was subject to an agreement in accordance with French data protection law (RGPD # MR004060220233). In accordance with national ethical directives, the requirement for written informed consent was waived. According to the French Public Health Code, another Institutional Review Board was not necessary for this research.

: Not applicable.

: the authors have no conflict of interest to declare.